Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
CorrectionErratum

Correction to “Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease”

Drug Metabolism and Disposition March 2019, 47 (3) 328; DOI: https://doi.org/10.1124/dmd.115.083907err
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

In the above article [Beaudoin JJ, Bezençon J, Cao Y, Mizuno K, Roth SE, Brock WJ, and Brouwer KLR (2019) Drug Metab Dispos 47(2):155-163; DOI: https://doi.org/10.1124/dmd.118.083907], the following errors were introduced during copyediting:

1) On page 156, in the last sentence, “nM” was incorrectly changed to “μM” twice, and “nmol/g” was incorrectly changed to “μM/g” once. The sentence should read: “The lower limits of quantitation were 5 nM, 50 nM, and 0.6 nmol/g tissue for the outflow perfusate, bile, and liver samples, respectively.”

2) On page 159, in the second sentence of the Fig. 2 legend, “nmol” was incorrectly changed to “nmol/l” once. The sentence should read: “Amounts (nmol) of TVP, DM-4103, and DM-4107 recovered at 60 min in isolated perfused livers from WT and PCK rats.”

3) On page 159, in portions of the second paragraph of the “Results” section, “nM” was incorrectly changed to “μM” in six instances. Starting at the fourth sentence, the paragraph should read: “However, at the end of the washout phase, the outflow perfusate concentration of TVP was 2.33-fold higher in PCK compared with the WT rat livers (PCK = 522.4±127.6 nM vs. WT = 224.6±162.3 nM, P= 0.0089). Starting at the sixth sentence, the paragraph should read: “A similar trend was seen for DM-4107, but the concentrations at 30 min (3.94-fold increase in PCK) and at the end of the washout (3.69-fold increase in PCK) were significantly different (PCK = 62.57±25.05 nM vs. WT = 15.89±8.67 nM, P = 0.0020, and PCK = 93.04±30.01 nM vs. WT = 25.23±19.38 nM, P = 0.0014, respectively; Fig. 3C).”

4) On page 159, in the second sentence of the Fig. 3 legend, “nM” was incorrectly changed to “μM” once. The sentence should read: “Concentration (nM) vs. time (min) profiles of (A) TVP, (B) DM-4103, and (C) DM-4107 in the outflow perfusate of isolated perfused livers (IPLs) from WT and PCK rats.”

5) On page 160, in the second sentence of the Fig. 4 legend, “nmol” was incorrectly changed to “nmol/L” once. The sentence should read: “Cumulative amount (nmol) vs. time (min) profiles of (A) TVP, (B) DM-4103, and (C) DM-4107 in the bile of isolated perfused livers (IPLs) from WT and PCK rats.”

6) On page 161, in the second sentence of the Fig. 6 legend, “nmol/hr” was incorrectly changed to “nmol/Ls per hr” twice. The sentence should read: “Appearance rate in outflow perfusate (nmol/hr) and biliary excretion rate (nmol/hr) vs. time (min) profiles of [(A and C), respectively] TVP and [(B and D), respectively] DM-4103 + DM-4107 in IPLs from WT and PCK rats.”

7) On page 161, in the second sentence of the Fig. 7 legend, “nM” was incorrectly changed to “μM” once. The sentence should read: “Total hepatocellular concentration (nM) vs. time (hr) profiles of (A) TVP and (B) DM-4103 + DM-4107 simulated in the hepatocellular space of isolated perfused livers from WT and PCK rats using the model depicted in Fig. 1.”

The HTML and PDF versions of the article have been corrected.

The compositor regrets any inconvenience these errors have caused.

  • Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 47 (3)
Drug Metabolism and Disposition
Vol. 47, Issue 3
1 Mar 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction to “Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease”
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CorrectionErratum

Correction to “Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease”

Drug Metabolism and Disposition March 1, 2019, 47 (3) 328; DOI: https://doi.org/10.1124/dmd.115.083907err

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
CorrectionErratum

Correction to “Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease”

Drug Metabolism and Disposition March 1, 2019, 47 (3) 328; DOI: https://doi.org/10.1124/dmd.115.083907err
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction to “Microbial Metabolites as Ligands to Xenobiotic Receptors: Chemical Mimicry as Potential Drugs of the Future”
  • Correction to “Dimethandrolone, a Potential Male Contraceptive Pill, is Primarily Metabolized by the Highly Polymorphic UDP-Glucuronosyltransferase 2B17 Enzyme in Human Intestine and Liver”
  • Correction to “Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo”
Show more Errata

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics